Acthera Therapeutics is Biotechnology in Switzerland that focus on hard-shelled liposomes business. Founded in 2019. They cover business area such as developer, hard-shell liposome, highly target release, potentially toxic therapeutic molecule, medical need, toxicity, many drug.
2019
( 5 years old in 2024 )
Hard-shelled Liposomes
-
Peter Merian-Strasse 45
4052 Basel
Switzerland
Private
developerhard-shell liposomehighly target releasepotentially toxic therapeutic moleculemedical needtoxicitymany drug
* We use standard office opening hours in near Acthera Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Acthera Therapeutics is Biotechnology business from Switzerland that founded in 2019 (5 years old in 2024), Acthera Therapeutics business is focusing on Hard-shelled Liposomes.
Acthera Therapeutics headquarter office and corporate office address is located in Peter Merian-Strasse 45 4052 Basel Switzerland.
Acthera Therapeutics was founded in Switzerland.
In 2024, Acthera Therapeutics is currently focus on hard-shelled liposomes sector.
Above is snippet of Google Trends for "hard-shelled liposomes" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Acthera Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
